Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
106,851,987
-
Total 13F shares
-
66,860,593
-
Share change
-
+12,154,851
-
Total reported value
-
$681,317,067
-
Price per share
-
$10.19
-
Number of holders
-
97
-
Value change
-
+$120,040,819
-
Number of buys
-
70
-
Number of sells
-
27
Institutional Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q4 2021
As of 31 Dec 2021,
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,860,593 shares.
The largest 10 holders included
Casdin Capital, LLC, BlackRock Inc., BAMCO INC /NY/, D1 Capital Partners L.P., Vitruvian Partners LLP, VANGUARD GROUP INC, Holocene Advisors, LP, Artisan Partners Limited Partnership, RIVER & MERCANTILE ASSET MANAGEMENT LLP, and Nine Ten Capital Management LLC.
This page lists
97
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.